J. Lipid Res.  Neurobiology of Lipids (ISSN1683-5506)
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1194/jlr.D600040-JLR200 on January 10, 2007

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow An erratum has been published
Right arrow All Versions of this Article:
D600040-JLR200v1
48/3/733    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zhang, B.
Right arrow Articles by Saku, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhang, B.
Right arrow Articles by Saku, K.
Journal of Lipid Research, Vol. 48, 733-744, March 2007
Copyright © 2007 by American Society for Biochemistry and Molecular Biology


Methods

Control of matrix effects in the analysis of urinary F2-isoprostanes using novel multidimensional solid-phase extraction and LC-MS/MS

Bo Zhang1 and Keijiro Saku

Department of Cardiology, Fukuoka University School of Medicine, Fukuoka, Japan

Published, JLR Papers in Press, January 10, 2007.

1 To whom correspondence should be addressed. e-mail: bozhang{at}fukuoka-u.ac.jp

F2-isoprostanes (F2-iPs), established markers of oxidative stress, exist as four sets of regioisomers. Simultaneous and specific determination of F2-iPs can be achieved by liquid chromatography-tandem mass spectrometry (LC-MS/MS). We developed novel methods for urine sample preparation and HPLC to control matrix-related ion suppression effects in the LC-MS/MS analysis of F2-iPs. A selective solid-phase extraction (SPE) wash protocol was developed with an Oasis HLB (hydrophilic-lipophilic balance) SPE cartridge using an elution profile of [3H]8-iso-prostaglandin (PG)F2{alpha} (iPF2{alpha}-III) when the methanol concentration was increased under acidic, neutral, and base wash conditions. A multidimensional (MD)-SPE method that incorporated size exclusion, reverse-phase chromatography, and normal-phase chromatography was developed using an Oasis HLB SPE cartridge and an HLB µElution SPE plate. Average extraction recoveries of the deuterated internal standards of iPF2{alpha}-III and iPF2{alpha}-VI were 62 ± 8% and 60 ± 10%. A buffer-free HPLC method for the separation of F2-iP isomers was developed on base-deactivated C8 columns. Average matrix effects for iPF2{alpha}-III and iPF2{alpha}-VI were 95 ± 6% and 103 ± 5%. The clean extraction of urine F2-iPs using MD-SPE and the separation of F2-iP isomers using a novel HPLC method did not cause apparent ion suppression in the analysis of iPF2{alpha}-III and iPF2{alpha}-VI using LC-MS/MS. These findings should be useful for establishing a routine LC-MS/MS method for the analysis of F2-iPs.

Supplementary key words liquid chromatography-tandem mass spectrometry • urine • ion suppression effects • buffer-free HPLC • sample preparation • iPF2{alpha}-VI







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Journal of Biological Chemistry 
 Molecular and Cellular Proteomics   ASBMB Today 
Copyright © 2007 by the American Society for Biochemistry and Molecular Biology.